Access
To read this story in full you will need to login or make a payment (see right).
Letter
Nature 451, 587-590 (31 January 2008) | doi:10.1038/nature06515; Received 12 July 2007; Accepted 27 November 2007
Open Innovation Challenges
-
Protect Enzyme from In Planta Degradation
A proposal for stable expression of an enzyme in corn seed is desired.
-
Efficient Chromosome Doubling: Plant Cell Division
The Seeker is looking for an efficient chromosome doubling method in plants and in particular, metho...
nature jobs
Group Director Discovery Biology / Infectious Disease
- Bristol-Myers Squibb
- Wallingford, CT
Scientist for Pilot Plant - Solid Dosage Forms
- Novo Nordisk
- Bagsværd, Denmark
Negative regulation of the deacetylase SIRT1 by DBC1
Wenhui Zhao1,3, Jan-Philipp Kruse1,3, Yi Tang1,3, Sung Yun Jung2, Jun Qin2 & Wei Gu1
- Institute for Cancer Genetics, and Department of Pathology College of Physicians and Surgeons, Columbia University, 1130 St Nicholas Avenue, New York, New York 10032, USA
- Departments of Biochemistry and Cell Biology, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030, USA
- These authors contributed equally to this work.
Correspondence to: Wei Gu1 Correspondence and requests for materials should be addressed to W.G. (Email: wg8@columbia.edu).
Abstract
SIRT1 is an NAD-dependent deacetylase critically involved in stress responses, cellular metabolism and, possibly, ageing1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15. The tumour suppressor p53 represents the first non-histone substrate functionally regulated by acetylation and deacetylation16, 17; we and others previously found that SIRT1 promotes cell survival by deacetylating p53 (refs 4–6). These results were further supported by the fact that p53 hyperacetylation and increased radiation-induced apoptosis were observed in Sirt1-deficient mice10. Nevertheless, SIRT1-mediated deacetylase function is also implicated in p53-independent pathways under different cellular contexts, and its effects on transcriptional factors such as members of the FOXO family and PGC-1
directly modulate metabolic responses1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15. These studies validate the importance of the deacetylase activity of SIRT1, but how SIRT1 activity is regulated in vivo is not well understood. Here we show that DBC1 (deleted in breast cancer 1) acts as a native inhibitor of SIRT1 in human cells. DBC1-mediated repression of SIRT1 leads to increasing levels of p53 acetylation and upregulation of p53-mediated function. In contrast, depletion of endogenous DBC1 by RNA interference (RNAi) stimulates SIRT1-mediated deacetylation of p53 and inhibits p53-dependent apoptosis. Notably, these effects can be reversed in cells by concomitant knockdown of endogenous SIRT1. Our study demonstrates that DBC1 promotes p53-mediated apoptosis through specific inhibition of SIRT1.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Human therapeutic proteins from silkwormsNature Biotechnology Research News (01 Jan 2003)
Research HighlightsNature Chemical Biology News and Views (01 Feb 2006)
See all 4 matches for News And ViewsRESEARCH
TIRAP: an adapter molecule in the Toll signaling pathwayNature Immunology Article (01 Sep 2001)
A GTP-binding adapter protein couples TRAIL receptors to apoptosis-inducing proteinsNature Immunology Article (01 Jun 2001)
See all 66 matches for Research
